Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

NCT07018947 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fundacion Clinic per a la Recerca Biomédica